Serum retinol, alpha-tocopherol and systemic inflammatory response in metastatic colorectal carcinoma patients treated with combination chemotherapy and cetuximab

Journal of Nutritional Science and Vitaminology

Volumn 56, Issue 4, 2010, Pages 222-226

  Melichar, Bohuslav ^a,b   Krčmová, Lenka ^b   Kalábová, Hana ^b   Holečková, Petra ^b   Kašparová, Markéta ^b   Plíšek, Jiří ^b   Hyšpler, Radomír ^b   Študentová, Hana ^a   Solichová, Dagmar ^b  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Alpha tocopherol; C reactive protein; Cetuximab; Colorectal carcinoma; Retinol

Indexed keywords

ALPHA TOCOPHEROL; C REACTIVE PROTEIN; CETUXIMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; RETINOL;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CARCINOMA; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFLAMMATION; MALE; PROGNOSIS;

EID: 77957746480     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.56.222     Document Type: Article

References (36)

1. Cunningham D, Hurnblet Y, Siena S, Khayat D, Bleiberg H, Santoro A, Bets D, Mueser M, Harstrick A, Verslype C, Chau I, Van Cutsem E. 2004. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 351: 337-345.
2. Bokemeyer C, Bondarenko I, Makhson A, Hartmann JT, Aparicio J, de Braud F, Donea S, Ludwig H, Schuch G, Stroh G, Loos AH, Zubel A, Koralewski P. 2009. Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer. J Clin Oncol 27: 663-671.
3. Van Cutsem E, Kohne CH, Hitre E, Zaluski J, Chien CRC, Makhson A, D Haens G, Pinter T, Lim R, Bodoky G, Roh JK, Folprecht G, Ruff P, Stroh C, Tejpar S, Schlichting M, Nippgen J, Rougier P. 2009. Cetuximab and chemotherapy as initial treatment for metastatic colrectal cancer. N Engl J Med 360: 1408-1417.
4. Faber M, Coudray C, Hida H, Mousseau M, Favier A. 1995. Lipid peroxidation products, and vitamin and trace element status in patients with cancer before and after chemotherapy, including adriamycin. A preliminary study. Biol Trace Elem Res 47: 117-123.
5. Faure H, Coudray C, Mousseau M, Ducros V, Douki T, Bianchini F, Cadet J, Favier A. 1996. 5-Hydroxymethyluracil excretion, plasma TBARS and plasma antioxidant vitamins in adriamycin-treated patients. Free Radic Biol Med 20: 979-983.
6. Weijl NI, Hopman GD, Wipkink-Bakker A, Lentjes EGWM, Berger HM, Cleton FJ, Osanto S. 1998. Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients. Ann Oncol 9: 1331-1337.
7. Debier C, Larondelle Y. 2005. Vitamins A and E: metabolism, roles and transfer to offspring. Br J Nutr 93: 153-174.
8. Delanian S, Porcher R, Balla-Mekias S, Lefaix JL. 2003. Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis. J Clin Oncol 21: 2545-2550.
9. Erhola M, Nieminen MM, Ojala A. 1998. Human plasma antioxidant capacity during radiotherapy for lung cancer: a clinical study. J Exp Clin Cancer Res 17: 325-330.
10. Pace A, Savarese A, Picardo M, Maresca V, Pacetti U, Del Monte G, Biroccio A, Leonetti C, Jandolo B, Cognetti F, Bove L. 2003. Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy. J Clin Oncol 21: 927-931.
11. Jonas RC, Puckett AB, Jones DP, Griffith DP, Szeszycki EE, Bergman GF, Furr CE, Tyre C, Carlson JL, Galloway JR, Blumberg JB, Ziegler TR. 2000. Plasma antioxidant status after high-dose chemotherapy: a randomized trial of parenteral nutrition in bone marrow transplantation patients. Am J Clin Nutr 72: 181-189.
12. High KP, Legault C, Sinclair JA, Cruz J, Hill K, Hurd DD. 2002. Low plasma concentrations of retinol and alphatocopherol in hematopoietic stem cell transplant recipients: the effect of mucositis and the risk of infection. Am J Clin Nutr 76: 1358-1366.
13. McMillan DC, Talwar D, Sattar N, Underwood M, O'Reilly DSJ, McArdle C. 2002. The relationship between reduced vitamin antioxidant concentrations and the systemic inflammatory response in patients with common solid tumours. Clin Nutr 21: 161-164.
14. Mayland C, Allen KR, Degg TJ, Bennet M. 2004. Micronutrient concentrations in patients with malignant disease: effect of the inflammatory response. Ann Clin Biochem 41: 138-141.
15. Melichar B, Cerman J, Malírová E. 2007. Successful management of infusion reaction accompanying the start of cetuximab therapy. Support Care Cancer 15: 445-449.
16. Urbanek L, Solichova D, Melichar B, Dvorak J, Svobodova I, Solich P. 2006. Optimization and validation of a high performance liquid chromatography method for the simultaneous determination of vitamins A and E human serum using monolithic column and diode-array detection. Anal Chim Acta 573-574: 267-272.
17. Simpson WG, Heys SD, Whiting PH, Eremin O, Broom J. 1995. Acute phase proteins and recombinant IL-2 therapy, prediction of response and survival in patients with colorectal cancer. Clin Exp Immunol 99: 143-147.
18. McMillan DC, Sattar N, Talwar D, O'Reilly J, McArdle CS. 2000. Changes in micronutrient concentrations following anti-inflammatory treatment in patients with gastrointestinal cancer. Nutrition 16: 425-428.
19. Banks RE, Forbes MA, Storr M, Higginson J, Thompson D, Raynes J, Illingworth JM, Perren TJ, Selby PJ, Whicher JT. 1995. The acute phase protein response in patients receiving subcutaneous IL-6. Clin Exp Immunol 102: 217-223.
20. Rosales FJ, Ritter SJ, Zolfaghari R, Smith JE, Ross AC. 1996. Effects of acute inflammation on plasma retinol, retinol-binding protein, and its mRNA in the liver and kidneys of vitamin A-sufficient rats. J Lipid Res 37: 962-971.
21. Beisel W. 1998. Infection-induced depression of serum retinol-a component of the acute phase response or a consequence? Am J Clin Nutr 68: 993-994.
22. Koyanagi A, Kuffo D, Gresely L, Shenkin A, Cuevas LE. 2004. Relationships between serum concentrations of C-reactive protein and micronutients, in patients with tuberculosis. Ann Trop Med Parasitol 98: 391-399.
23. Talwar D, Ha TKK, Scott HR, Cooney J, Fell GS, O'Reilly DS, Lean MEJ, McMillan DC. 1997. Effect of inflammation on measures of antioxidant status in patients with non-small cell lung cancer. Am J Clin Nutr 66: 1283-1285.
24. Melichar B, Kalabova H, Krcmova L, Urbánek L, Hyspler R, Malirova E, Solichova D. 2007. Serum alpha-tocopherol, retinol and neopterin during paclitaxel/carboplatin chemotherapy. Anticancer Res 27: 4397-4401.
25. Slater GH, Ren CJ, Siegel N, Williams T, Barr D, Wolfe B, Dolan K, Fielding GA. 2004. Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery. J Gastrointest Surg 8: 48-55.
26. Johnson EJ, Krasinski SD, Howard LJ, Alger SA, Dutta SK, Russell RM. 1992. Evaluation of vitamin A absorption by using oil-soluble and water-miscible vitamin A preparations in normal adults and in patients with gastrointestinal disease. Am J Clin Nutr 55: 857-864.
27. Melichar B, Dvorak J, Krcmova L, Hyspler R, Urbánek L, Solichova D. 2008. Intestinal permeability and vitamin A absoption in patients with chemotherapy-induced diarrhea. Am J Clin Oncol 31: 580-584.
28. Segaert S, Van Cutsem E. 2005. Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors. Ann Oncol 16: 1425-1433.
29. Melichar B, Nemcová I. 2007. Eye complications of cetuximab therapy. Eur J Cancer Care 16: 439-443.
30. Kim HS, Arai H, Arita M, Sato Y, Ogihara T, Tamai H, Inoue K, Mino M. 1996. Age-related changes of alphatocopherol transfer protein expression in rat liver. J Nutr Sci Vitaminol 42: 11-18.
31. Packer L, Valacchi G. 2002. Antioxidants and the response of skin to oxidative stress: vitamin E as a key indicator. Skin Pharmacol Appl Skin Physiol 15: 282-290.
32. Thiele JJ, Weber SU, Packer L. 1999. Sebaceous gland secretion is a major physiologic route of vitamin E delivery to skin. J Invest Dermatol 113: 1006-1010.
33. Briganti S, Picardo M. 2003. Antioxidant activity, lipid peroxidation and skin diseases. What is new. J Eur Acad Dermatol Venereol 17: 663-669.
34. Steinberg D. 1997. Oxidative modification of LDL and atherogenesis. Circulation 95: 1062-1071.
35. Keaney JF, Guo Y, Cunningham D, Swaery GT, Xu A, Vita JA. 1996. Vascular incorporation of alpha-tocopherol prevents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation. J Clin Invest 98: 386-394.
36. Salonen JT, Nyyssonen K, Salonen R, Lakka H-M, Kaikkonen J, Porkkala-Sarataho E, Voutillainen S, Lakka TA, Rissanen T, Leskinen L, Tuomainen T-P, Valkonen V-P, Ristonmaa U, Poulsen HE. 2000. Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. J Intern Med 248: 377-386.